Zentalis Pharmaceuticals, Inc.
NASDAQ:ZNTL
4.36 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 40.56 | 2.104 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0.327 | 0.324 | 0.337 | 0.348 | 0.344 | 0.36 | 0.359 | 0.375 | 0.348 | 0.344 | 0.209 | 0.137 | 0.119 | 0.079 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| -0.327 | 40.236 | 1.767 | -0.348 | -0.344 | -0.36 | -0.359 | -0.375 | -0.348 | -0.344 | -0.209 | -0.137 | -0.119 | -0.079 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 0 | 0.992 | 0.84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 48.386 | 49.585 | 51.557 | 46.765 | 42.684 | 48.584 | 40.616 | 42.181 | 43.825 | 46.112 | 38.439 | 53.998 | 44.77 | 38.394 | 29.521 | 24.67 | 17.452 | 13.258 | 11.869 | 10.739 | 8.689 | 7.089 |
| Algemene en administratieve kosten
| 16.762 | 15.74 | 16.365 | 15.953 | 15.664 | 16.369 | 11.138 | 12.012 | 19.636 | 11.767 | 9.754 | 8.872 | 10.362 | 11.953 | 10.724 | 10.097 | 9.924 | 3.141 | 3.036 | 1.844 | 1.946 | 1.633 |
| Verkoop- en marketingkosten
| -0.327 | -0.324 | -0.337 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 16.435 | 15.416 | 16.028 | 15.953 | 15.664 | 16.369 | 11.138 | 12.012 | 19.636 | 11.767 | 9.754 | 8.872 | 10.362 | 11.953 | 10.724 | 10.097 | 9.924 | 3.141 | 3.036 | 1.844 | 1.946 | 1.633 |
| Overige kosten
| -16.435 | 0 | 0 | 0 | 45.568 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.044 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.012 |
| Bedrijfskosten
| 64.821 | 65.001 | 67.585 | 62.718 | 58.348 | 64.953 | 51.754 | 54.193 | 63.461 | 57.879 | 48.193 | 62.87 | 55.132 | 50.347 | 40.245 | 34.767 | 27.376 | 16.399 | 14.905 | 12.583 | 10.635 | 8.722 |
| Bedrijfsresultaat
| -65.148 | -24.765 | -67.922 | -62.718 | -103.916 | -64.953 | -51.754 | -54.193 | -63.461 | -57.879 | -48.193 | -62.87 | -55.132 | -50.347 | -40.245 | -34.767 | -27.376 | -16.399 | -14.905 | -12.583 | -10.635 | -8.722 |
| Bedrijfsresultaat ratio
| 0 | -0.611 | -32.282 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| -22.863 | 34.948 | 6.848 | 7.209 | -41.117 | 4.109 | 3.232 | 1.905 | 0.424 | 0.426 | 0.088 | 51.681 | 0.115 | -0.044 | 0.315 | 0.12 | 0.084 | 0.164 | -0.139 | 0.012 | 0.049 | -0.012 |
| Inkomen voor belasting
| -88.011 | 10.183 | -61.074 | -55.509 | -99.465 | -60.844 | -48.522 | -52.288 | -63.037 | -57.453 | -48.105 | -11.189 | -55.017 | -50.248 | -39.93 | -34.647 | -27.292 | -16.235 | -14.546 | -12.571 | -10.586 | -8.66 |
| Inkomen voor belasting ratio
| 0 | 0.251 | -29.028 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0.266 | 0.143 | -0.135 | 0.031 | -0.605 | 0.108 | -0.36 | -0.159 | 0.017 | 0.033 | 0.159 | -0.697 | 0.045 | 0.196 | 0.426 | 0.018 | -0.435 | -0.109 | -0.538 | 0.001 | 0.011 | 0.003 |
| Nettowinst
| -88.277 | 10.068 | -60.917 | -55.528 | -112.527 | -60.952 | -48.162 | -52.129 | -63.054 | -57.486 | -50.059 | -4.191 | -54.574 | -49.901 | -40.303 | -34.555 | -26.857 | -16.126 | -14.506 | -12.344 | -10.47 | -8.343 |
| Nettowinstmarge
| 0 | 0.248 | -28.953 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -1.24 | 0.14 | -0.86 | -0.79 | -1.85 | -1.03 | -0.81 | -0.92 | -1.23 | -1.27 | -1.11 | -0.094 | -1.34 | -1.24 | -1.01 | -0.91 | -0.78 | -0.47 | -0.44 | -0.68 | -0.58 | -0.46 |
| Verwaterde WPA
| -1.24 | 0.14 | -0.86 | -0.79 | -1.85 | -1.03 | -0.81 | -0.92 | -1.23 | -1.27 | -1.11 | -0.094 | -1.34 | -1.24 | -1.01 | -0.91 | -0.78 | -0.47 | -0.42 | -0.68 | -0.58 | -0.46 |
| EBITDA
| -64.821 | -24.441 | -67.585 | -69.579 | -16.887 | -68.702 | -54.627 | -55.723 | -63.537 | -57.961 | -48.281 | -114.414 | -55.128 | -50.268 | -40.56 | -34.836 | -27.422 | -16.361 | -14.864 | -12.57 | -10.66 | -8.701 |
| EBITDA ratio
| 0 | -0.603 | -32.122 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |